- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
4. In regulation 3A (interpretation of Part)(1)—
(a)in paragraph (1), after sub-paragraph (b), insert—
“(c)a reference to a country does not include a reference to the overseas territories and dependencies of that country unless otherwise stated.”;
(b)in paragraph (2)—
(i)in the definition of “authorised vaccine”, in sub-paragraph (c), for the words from “would be authorised” to the end, substitute—
“—
(i)would be authorised as provided for in paragraph (a)(i) or (ii) if the doses were received in the United Kingdom, or
(ii)are listed in lines 10, 11 or 13 of the Guidance Document “Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process” published by the World Health Organisation on 11th November 2021(2), and authorised or certified in a relevant country listed in paragraph (4);”;
(ii)in the definition of “NHS COVID pass”—
(aa)after “records”, insert “available”;
(bb)after “NHS.uk or”, insert “in”;
(iii)after the definition of “NHS Wales”, insert—
“North American Certificate” means, in relation to a State listed in the table in paragraph (2B), the certificate identified in the corresponding row of the second column of that table;”;
(iv)after the definition of “NHS Wales”, insert—
““Regulation (EU) 2021/953” means Regulation (EU) 2021/953 of the European Parliament and of the Council of 14 June 2021 on a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU Digital COVID Certificate) to facilitate free movement during the COVID-19 pandemic(3)”.
(c)after paragraph (2), insert—
“(2A) The following countries and territories are approved third countries or territories for the purposes of this Part—
Albania
Armenia
Faroe Islands
Israel
Morocco
North Macedonia
Panama
Turkey
Ukraine.
(2B) The table referred to in the definition of “North American Certificate” in paragraph (2) is—
State | Certificate Name |
---|---|
California | Digital COVID-19 Vaccine Record |
New York | Excelsior Pass Plus |
Washington State | WA Verify”; |
(d)in paragraph (3), in the opening words, after “paragraph (2)” insert “except in the definition of “North American Certificate””;
(e)in paragraph (4), in the list of countries and territories, at the appropriate places insert entries for—
“Belarus
Bolivia
Democratic Republic of the Congo
Dominican Republic
Ecuador
Laos
Libya
Malawi
Mozambique
Samoa
Senegal
Vanuatu
Zambia
Zimbabwe.”.
Regulations 3A to 3K were inserted by S.I. 2021/1107.
A copy may be downloaded from https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_11Nov2021.pdf. A hard copy may be obtained from the Department of Health and Social Care, 39 Victoria Street, London, SW1H 0EU.
OJ L 211, 15.6.21, p.1.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: